Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, accurately characterizing gene therapy products and standing behind safety and efficacy is crucial to drug developers bringing gene therapies into and through the clinic. In […]

Eli Lilly’s ‘triple G’ drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up to 24% weight loss, a new record for the obesity field has been set and the time to get ahead of the curve is now. In parallel, we’re witnessing history being made with […]

Enter the inaugural Cell Therapy for Autoimmune Disease Summit, a pioneering platform singularly focused on uniting and empowering this community for the first time. Experts will delve into cutting-edge frontiers of pre-clinical, translational, and clinical advancements encompassing all cell-based therapies, including CAR-T, Treg, and MSC, with the shared objective of developing better therapies for patients […]

The Donor Selection & Cell Source Summit is your ultimate platform to explore the latest global regulatory requirements and differences on donor testing, understand the novel genome sequencing data being used to inform donor selection, and forge new partnerships to ease logistical coordination with donation sites to ensure exclusive availability of selected donor pools. Join Senti Biosciences, […]

CRISPR represents the next frontier in the cell and gene therapy landscape. Spearheaded by the first gene edited therapeutic awaiting FDA approval, a mounting wave of innovative technology developments and therapeutic applications are leading to a paradigm shift in our global healthcare systems. To this end, the 4th Annual CRISPR 2.0 Congress is your definitive […]

The Advanced Purification for Complex Biologics Summit is the first and only standalone conference focused on purification for biologics and novel modalities bringing together purification, CMC and MSAT professionals to collaborate and remove purification bottlenecks to meet market delivery timelines. This in-depth 3-day event will feature the latest breakthroughs and cutting-edge content in AI and […]

The 3rd ADC Target Selection Summit (December 5-7 | Boston, MA). This is the ultimate cover-to-cover conference providing insights to help you optimize the pairing of target, antibody, and linker-payload and develop the next generation of clinically successful ADCs beyond HER2 and TROP2. See the full program here. As the number of new clinical ADC […]

Enzyme Engineering Enabling Scalable Industrial Biotransformation for Sustainable API Production In 2023, an era of advanced enzyme engineering technology is rapidly enabling the generation of game-changing enzymes for novel transformations. As witnessed for Merck’s Islatravir and BMS’ ERED/KRED biocatalytic cascade recognition, industries are fast transitioning towards biocatalysis to capitalize on more sustainable means of synthesis. The 3rd Applied Biocatalysis Summit […]

200+ Attendees | 33+ World-Class Speakers | 23+ Data Driven Case Studies Returning to Boston this December for its 6th year, the RNA-Targeted Drug Discovery & Development Summit is the only industry-dedicated forum solely focused on small molecules targeting RNA, with a core focus on improving selectivity and specificity to enable safe and effective drugs into […]

The Health Economics & Outcomes Research Summit is a focused intimate gathering of HEOR professionals, moving past basic introductions to advanced tactical and strategic conversations best leveraging innovative methods to demonstrate the value proposition of new drugs to secure formulary and market access. Hear cutting-edge case studies into evidence generation, modeling and real-world evidence across oncology, […]

Following recent struggles in the industry, the leading annual 8th Oncolytic Virotherapy Summit returns to Boston, MA in December (12-14), as the industry’s definitive, and most comprehensive forum. Bringing you 29+ world-class speakers, 10+ hours of networking, 2-panel discussions, 1 pre-conference focus day & more. This event will be showcasing brand-new pivotal data to ensure a pathway […]

Bringing the covalency field under one roof for the first time, the inaugural Covalent Drug Discovery Summit comes to Boston this December – gathering 80+ covalent drug specialists from the likes of Amgen, Revolution Medicines, Novartis, Totus Medicines, Covant Therapeutics and more. This is a unique opportunity to network with an audience of CXOs, VPs, Directors and […]

The inaugural Gene Therapy Process Development Summit is a must-attend to discover the latest insights to bridge the gap between R&D and process development, ensuring that high-quality gene therapies are manufactured repeatably, at scale, and in a cost-effective manner. Join us in Philadelphia to discover and learn the latest insights through case study presentations, informative […]